Author

P. Ballerini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

A. Petit· 2 shared B. Uzan· 2 shared F. Pflumio· 2 shared J. Calvo· 2 shared L. Renou· 2 shared A. Kypraios· 1 shared B. Gaillard· 1 shared C. Antoniewski· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Petit

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including Hepatocyte Growth factor

C. Le Maout, L. Fahy, L. Renou, C. Devanand, C. Duwat, V. Barroca, M. Le Gall, P. Ballerini, A. Petit, J. Calvo, B. Uzan, F. Pflumio, V. Petit

This study identifies an inflammatory microenvironment in T-ALL that supports progression, with HGF as a potential therapeutic target.

bioRxiv · Apr 24, 2024Cancer Biology

High CD44 expression identifies rare chemoresistant leukemic cells endowed with enhanced E-Selectin binding in T-ALL

J. Calvo, I. Naguibneva, A. Kypraios, B. Uzan, B. Gaillard, L. Bellenger, L. Renou, C. Antoniewski, H. Lapillone, A. Petit, P. Ballerini, S. J. Mancini, T. Marchand, J.-F. Peyron, F. Pflumio

The paper identifies a chemoresistant leukemic stem cell population in T-ALL with high CD44 expression and enhanced E-selectin binding, associated with poor prognosis and relapse.

bioRxiv · Dec 20, 2023 · PreprintCancer Biology